P3.02b-006 Role of TP53 Mutations in Determining Primary Resistance to First-Line Tyrosine Kinase Inhibitors in EGFR-Mutated NSCLC Patients

Subjects

Subjects :

Pulmonary and Respiratory Medicine
Primary (chemistry)
Oncology
business.industry
First line
Cancer research
Medicine
Tp53 mutation
business
Molecular biology
Tyrosine kinase

Details

ISSN :

15560864

Volume :

12

Database :

OpenAIRE

Journal :

Journal of Thoracic Oncology

Accession number :

edsair.doi...........4c2bd153b0fdb6f3c1a972f4ba9661a2

Full Text :

https://doi.org/10.1016/j.jtho.2016.11.1673